Related Experiment Video
Updated: Nov 7, 2025
11:22
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
30.5K
Decoding the matrix: multiomics reveals host-microbe biomarker for inflammatory bowel disease
The Journal of Clinical Investigation
|May 3, 2021
Summary
Researchers discovered a link between DUOX2 gene variants and elevated IL-17C levels in inflammatory bowel disease (IBD) patients. This finding from big data analysis may lead to new biomarkers for improved IBD clinical care.
Area of Science:
- Gastroenterology
- Immunology
- Genetics
- Microbiome Research
Background:
- Inflammatory bowel disease (IBD) is a chronic intestinal inflammation linked to genetic factors and gut microbiome changes.
- Extensive multiomics data has been generated, but mechanistic insights into host-microbe interactions remain crucial for patient care.
- Identifying specific genetic and molecular drivers is key to advancing IBD treatment strategies.
Purpose of the Study:
- To decode complex multiomics data to uncover mechanistic links in IBD.
- To identify potential biomarkers for improved clinical management of IBD patients.
- To investigate the relationship between genetic variants and inflammatory markers in IBD.
Main Methods:
- Analysis of anonymized multiomics data from over 2800 individuals.
- Investigated associations between genetic variants and plasma cytokine levels.
- Utilized big data analytics to decipher complex biological datasets.
Main Results:
- Identified a significant association between heterozygous carriers of deleterious DUOX2 variants and elevated plasma IL-17C levels.
- Demonstrated a link between specific genetic variations and a key inflammatory marker in IBD.
- Highlighted the power of large-scale data analysis in driving biological discovery.
Conclusions:
- Harnessing big data can yield mechanistic insights into complex diseases like IBD.
- DUOX2 variants and elevated IL-17C represent a potential biomarker for IBD.
- These findings pave the way for improved diagnostic and therapeutic approaches in IBD management.
More Related Videos
09:49Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection
Published on: November 18, 2022
2.4K
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
20.0K
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
476
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
476
01:30Inflammatory Bowel Disease II: Crohn's Disease
529
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
529
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
508
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
508
01:29Inflammatory Bowel Disease IV: Pharmacological Management
259
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
259
01:17Irritable Bowel Syndrome I: Introduction
609
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
609
01:17Chronic Bowel Disorders: Introduction
600
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
600